Boston Scientific Corp. (NYSE: BSX) Q4 2020 earnings call dated Feb. 03, 2021
Corporate Participants:
Susie Lisa — Vice President, Investor Relations
Michael F. Mahoney — Chairman and Chief Executive Officer
Daniel J. Brennan — Executive Vice President and Chief Financial Officer
Kenneth Stein — Senior Vice President and Chief Medical Officer, CRM
Analysts:
Robert A. Hopkins — Bank of America Merrill Lynch — Analyst
David Ryan Lewis — Morgan Stanley — Analyst
Lawrence Biegelsen — Wells Fargo Securities — Analyst
Joanne Wuensch — Citi — Analyst
Robert Marcus — J.P. Morgan — Analyst
Matthew Taylor — UBS — Analyst
_________
To read the full earnings call transcript, click here
Most Popular
Key highlights from Deere & Co.’s (DE) Q4 2024 earnings results
Deere & Company (NYSE: DE) reported its fourth quarter 2024 earnings results today. Worldwide net sales and revenues decreased 28% year-over-year to $11.14 billion. Net income was $1.24 billion, or
NVDA Earnings: Nvidia Q3 profit jumps, beats estimates
NVIDIA Corporation (NASDAQ: NVDA) on Wednesday reported a sharp increase in adjusted profit and revenue for the third quarter of 2025. Earnings also topped analysts' estimates. The tech firm’s revenues
Lowe’s Companies (LOW): A few points to note about the Q3 2024 performance
Shares of Lowe’s Companies, Inc. (NYSE: LOW) rose over 1% on Wednesday. The stock has gained 8% over the past three months. The company delivered better-than-expected earnings results for the
Listen On
